Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-18-012608
Filing Date
2018-10-17
Accepted
2018-10-17 18:53:25
Documents
1
Period of Report
2018-10-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_153981679009475.html 4  
1 FORM 4 wf-form4_153981679009475.xml 4 3641
  Complete submission text file 0001628280-18-012608.txt   4997
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Issuer) CIK: 0001479290 (see all company filings)

EIN.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O REVANCE THERAPEUTICS, INC. 7555 GATEWAY BOULEVARD NEWARK CA 94560
Business Address
Zavodnick Todd Erik (Reporting) CIK: 0001660467 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36297 | Film No.: 181127265